Interstitial Lung Disease Trial, Recruiting (NCT07300696)

Interstitial Lung Disease Trial, Recruiting NCT07300696 Sponsor: University Hospital Heidelberg Condition: Interstitial Lung Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07300696 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Interstitial Lung Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been newly diagnosed with, are suspected of having, or are being monitored for one of these lung conditions: idiopathic pulmonary fibrosis (IPF), hypersensitivity pneumonitis (HP), or idiopathic non-specific interstitial pneumonia (iNSIP), and your doctor has already recommended a routine high-resolution chest scan (HRCT) for this reason
You are able to understand and agree to take part in the study (give informed consent)
You are able to lie still for the full duration of the imaging scans

Who may not be able to join:

You are currently pregnant or breastfeeding
You are under 18 years of age, or you are unable to give informed consent yourself
You have a medical condition that might make it difficult to follow the study's requirements (confirm with trial site)
You have any reason you cannot have an MRI scan — for example, if you have previously had an allergic reaction to the contrast dye used in MRI scans, or if your kidneys are not working well enough (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07300696

Sponsor: University Hospital Heidelberg

Phase: Not Applicable

Status: Recruiting

Condition: Interstitial Lung Disease

More information: https://clinicaltrials.gov/study/NCT07300696

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been newly diagnosed with, are suspected of having, or are being monitored for one of these lung conditions: idiopathic pulmonary fibrosis (IPF), hypersensitivity pneumonitis (HP), or idiopathic non-specific interstitial pneumonia (iNSIP), and your doctor has already recommended a routine high-resolution chest scan (HRCT) for this reason
You are able to understand and agree to take part in the study (give informed consent)
You are able to lie still for the full duration of the imaging scans

Who may not be able to join:

You are currently pregnant or breastfeeding
You are under 18 years of age, or you are unable to give informed consent yourself
You have a medical condition that might make it difficult to follow the study's requirements (confirm with trial site)
You have any reason you cannot have an MRI scan — for example, if you have previously had an allergic reaction to the contrast dye used in MRI scans, or if your kidneys are not working well enough (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University Hospital Heidelberg

Registry

ClinicalTrials.gov

Start date

20 November 2025

Est. completion

1 February 2027

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Identification of ILD Subtypes Using Baseline MRI Metrics

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov